Drug Type Gene editing |
Synonyms- |
Target |
Action modulators |
Mechanism PLOD1 modulators(procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ehlers-Danlos Syndrome | Preclinical | United States | 18 Aug 2024 |